ACE2 and COVID-19: Since ACE2 was identified as the receptor of SARS-CoV-2 (Hoffmann et al., 2020; Zhou et al., 2020), ACE2 upregulation with consequently facilitated viral uptake might aggravate lung injury and fatal outcome in the case of COVID-19.